使用栓塞保护装置行肠系膜上动脉支架置入术治疗急慢性肠系膜缺血
该回顾性研究纳入2007至2016年连续接受肠系膜上动脉支架置入的179例患者,其中65例(36%)选择性使用栓塞保护装置。技术成功率100%,66%患者滤器捕获肉眼碎片,6%发生远端栓塞,急性肠系膜缺血患者早期死亡2例(12%)。作者认为双导丝技术下使用栓塞保护装置安全可行。
要点
- 肠系膜上动脉支架置入中选择性使用栓塞保护装置的技术成功率为100%。
- 66%患者滤器捕获肉眼碎片,其中49%为大碎片。
- 尽管使用栓塞保护装置,6%患者仍发生远端栓塞。
核心结论
- 在双导丝技术下,肠系膜上动脉支架置入时使用栓塞保护装置安全可行。
- 当对存在急性症状、闭塞或严重钙化病变的患者选择性应用滤器时,约三分之一患者可见大块肉眼碎片。
- 尽管使用栓塞保护装置,6%患者发生远端栓塞,并均经导管抽吸装置成功处理。
研究设计与样本
- 回顾性综述,纳入2007年至2016年连续接受肠系膜上动脉支架置入并使用栓塞保护装置的患者。
- 共179例患者接受肠系膜上动脉支架置入,其中65例(36%)使用了栓塞保护装置。
- 栓塞保护装置选择性用于存在闭塞、严重钙化或急性血栓的患者。
主要发现
- 使用栓塞保护装置的患者平均年龄73±11岁,女性49例(75%)。
- 临床表现:慢性肠系膜缺血48例(74%),急性肠系膜缺血或慢性肠系膜缺血急性加重17例(26%)。
- 使用栓塞保护装置的指征:严重钙化22例(34%),急性血栓18例(28%),完全闭塞16例(25%)。
- 支架类型:裸金属支架33例,覆膜支架26例,两者均用6例。
- 辅助治疗:溶栓7例,血栓清除4例,斑块旋切3例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of the study was to report the feasibility and results of superior mesenteric artery (SMA) stenting using embolic protection devices (EPDs) to treat acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). METHODS: A retrospective review was conducted of consecutive patients who underwent SMA stenting with EPDs from 2007 to 2016. EPDs were used selectively in patients with occlusions, severe calcification, or acute thrombus. A two-wire technique with SpiderFX 0.014-inch filter wire (Medtronic, Minneapolis, Minn) combined with a 0.018-inch wire was used to provide support and to facilitate stenting and EPD retrieval. Presence of macroscopic debris in the EPD was recorded and graded as minor (minimal debris) or major (large thrombus or plaque). End points were technical success, presence of EPD debris, embolization, early morbidity, and mortality. RESULTS: SMA stenting was performed in 179 patients, of whom 65 (36%) had EPDs. The mean age was 73 ± 11 years, and 49 were female (75%). Clinical presentation was CMI in 48 patients (74%) and AMI or acute-on-CMI in 17 (26%). Indications for EPD were severe calcification in 22 patients (34%), acute thrombus in 18 (28%), and total occlusion in 16 (25%). Bare-metal stents were used in 33 patients, covered stents in 26, and both types in 6. Adjunctive therapy included thrombolysis in seven patients, thrombectomy in four, and atherectomy in three. Technical success was 100%. There were no instances of filter retention or arterial trauma due to filter manipulation. Distal embolization was noted in four patients (6%), of whom two had AMI. All large emboli were retrieved using catheter aspiration devices, but one small distal embolus was left untreated with no clinical consequences. Two patients had vessel spasm treated by nitroglycerin. Macroscopic debris was noted in 43 patients (66%) and was major in 21 (49%) or minor in 22 (51%). Of the patients with AMI, five (29%) required exploratory laparotomy and four (23%) had bowel resection. Eight additional patients (12%) had early complications (five CMI, three AMI), including cardiac complications, brachial hematoma, acute cholecystitis, and acute respiratory distress syndrome in two patients each. There were no deaths among CMI patients and two early deaths (12%) among those who had AMI. CONCLUSIONS: Use of EPDs during SMA stenting is safe and feasible with a two-wire technique. Large macroscopic debris was noted in one-third of the patients when the filter was applied selectively in patients with acute symptoms, occlusions, or severely calcified lesions. Despite the use of EPD, distal embolization occurred in 6% of patients and was successfully treated using catheter aspiration devices.
引用
- Mendes BC, Oderich GS, Tallarita T, et al. Superior mesenteric artery stenting using embolic protection device for treatment of acute or chronic mesenteric ischemia. J Vasc Surg. 2018. PMID: 29685508. doi:10.1016/j.jvs.2017.12.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。